BACLOFEN
| Brand name | LYVISPAH |
|---|---|
| Active ingredient | BACLOFEN |
| Strength | 5MG/PACKET |
| Dosage form | GRANULE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | November 2021 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 11850225 | September 2041 | product |
| 11491125 | September 2041 | product |
| 10792262 | July 2039 | product |
| 11654124 | July 2039 | product |
| 11931328 | July 2039 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.